Corvus Pharmaceuticals (CRVS) Shares Outstanding (Diluted) (2016 - 2026)

Corvus Pharmaceuticals (CRVS) Shares Outstanding (Diluted) (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 52.24 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.51 Bn
4 NuCana 279.75 Bn 279.75 Bn - 10.00
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 256.30 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 107.70 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - 680.00
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 64.41 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 198.10 Mn
10 Corvus Pharmaceuticals 1.23 Bn 1.23 Bn - 90.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 90.00 Mn
Dec 31, 2025 79.74 Mn
Sep 30, 2025 82.84 Mn
Jun 30, 2025 77.77 Mn
Mar 31, 2025 75.15 Mn
Dec 31, 2024 60.99 Mn
Sep 30, 2024 66.70 Mn
Jun 30, 2024 59.71 Mn
Mar 31, 2024 49.04 Mn
Dec 31, 2023 48.03 Mn
Sep 30, 2023 48.97 Mn
Jun 30, 2023 47.50 Mn
Mar 31, 2023 46.56 Mn
Dec 31, 2022 46.55 Mn
Sep 30, 2022 46.55 Mn
Jun 30, 2022 46.55 Mn
Mar 31, 2022 46.55 Mn
Dec 31, 2021 41.85 Mn
Sep 30, 2021 43.95 Mn
Jun 30, 2021 42.25 Mn